News from Quartz
What is your interest today?
Tariffs
Investors
Ceo
Stock
Shares
Earnings
Stocks
Eqs
China
Cet
Nasdaq
Investment
Markets
Wall Street
Tesla
Nvidia
Trade
Inflation
Revenue
Securities
Class Action
Stock Market
Bitcoin
Economy
Company
Us
Federal Reserve
Sales
Apple
Prices
Trade War
Sp 500
Pvr
Ipo
Crypto
Interest Rates
Companies
Amazon
Shareholders
Federal Securities Laws
German Securities Trading Act
Voting Rights
Guidance
Warren Buffett
Trading
Gop
Elon Musk
Securities Laws
Berkshire Hathaway
Investor
Banks
Same Store Sales
Magnificent Seven
Scrutiny
Lease
Bbei
Semiconductor Companies
Egm
Plane Manufacturer
Trade Turbulence
Quartz • May 30, 2025
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Despite its initial leadership in the growing weight loss medication sector, Novo Nordisk has recently experienced a decline in market share compared to Eli Lilly, affecting its fi...
Read Full Article →
Quartz • May 12, 2025
Eli Lilly stock sinks as pharma misses out on the market rally
Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...
Read Full Article →
Quartz • May 12, 2025
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...
Read Full Article →